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among children in northern Israel from 1992 to
2009: a retrospective study
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Background: Determining the background incidence of intussusception is important in countries implementing
rotavirus immunization. Rotavirus immunization was introduced into the routine infant immunization program in
Israel during late 2010. Incidence and risk factors for intussusception were examined in children aged less than five
years between 1992 and 2009.
Methods: Data were collected from medical records of children hospitalized due to intussusception (N = 190), and
from control children (N = 295), at Carmel and Hillel Yaffe hospitals in northern Israel.
Results: The average annual incidence of intussusception in Jewish and Arab children aged less than five years
was estimated at 36.1 (95% CI 17.0-76.5) vs. 23.2 per 100,000 (95% CI 9.3-57.9); for infants less than 12 months of
age- 128.1 (95% CI 53.0-309.6) vs. 80.1 (95% CI 29.1-242.6) per 100,000. The risk of intussusception was higher in
infants aged 3–5 months: OR 5.30 (95% CI 2.11-13.31) and 6–11 months: OR 2.53 (95% CI 1.13-5.62) when compared
to infants aged less than 3 months; in those living in low vs high socioeconomic communities: OR 2.81 (95% CI
1.45-5.43), and in children with recent gastroenteritis: OR 19.90 (95% CI 2.35-168.32) vs children without recent
gastroenteritis. Surgical reduction was required in 23.2%. The likelihood of surgery was significantly increased in
patients presenting with bloody stool, in Arabs and those who were admitted to Hillel Yaffe Hospital.
Conclusions: The incidence of intussusception prior to universal rotavirus immunization was documented in
northern Israel. Despite the lower incidence, Arab patients underwent surgery more often, suggesting delayed
hospital admission of Arab as opposed to Jewish patients.
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Intussusception is among the most common abdominal
emergencies among young children [1-4]. Symptoms in-
clude sudden onset of vomiting, abdominal pain, intermit-
tent lethargy and irritability, and rectal bleeding that has
been described as “currant jelly” [3-6]. Reduction is usually
accomplished by air or barium enema, and in some cases
by surgery, with or without bowel resection [3,4,6]. Intus-
susception primarily affects young children [3,5], with high-
est incidence in infants aged 4–10 months [3-5]. Reported* Correspondence: khitam15@yahoo.com
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unless otherwise stated.yearly estimates of intussusception vary among populations
and regions from 20 to 100 per 100,000 infants [3,7-9], but
a higher incidence has also been reported [10].
The causes of intussusception are not fully understood,
yet, there is evidence linking recent episodes of gastro-
enteritis and increased risk of intussusception [11,12].
Adenovirus was repeatedly recovered in higher propor-
tions from fecal samples of patients with intussusception
compared with control children [13-15], however no asso-
ciation has been found between natural rotavirus infection
and intussusception [15-17].
In 1998 the reassortant rhesus human tetravalent oral
rotavirus vaccine (RotaShield, Wyeth-Lederle, Pearl River,
NY) was licensed in the United States. Shortly after
its introduction into the routine childhood vaccinationl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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within 2 weeks after immunization with the first dose [1
intussusception case per 10,000 vaccinees [18-20]]. Conse-
quently the vaccine was withdrawn from the market in
1999. Large clinical trials with two recent oral rotavirus
vaccines (RotaTeq (Merck) [21] and Rotarix (GSK) [22]),
and early post-marketing studies [23,24] showed no sig-
nificant increase in post-immunization intussusception.
However, later studies showed that in some settings e.g.,
Australia, and Mexico, there is an increased risk of intus-
susception during the first week post vaccination with the
first dose of either rotavirus vaccine [25-27]. At present,
this rare adverse event is estimated at about 1–2 intussus-
ception cases per 100,000 vaccine recipients [28,29], none-
theless the vaccine’s benefits clearly exceed this small risk,
thus rotavirus vaccines are recommended for use world-
wide [29]. It is important to establish the baseline inci-
dence of intussusception to assess the safety of rotavirus
vaccines [3,29,30] in countries considering the introduc-
tion of rotavirus vaccination.
In Israel, rotavirus was found to be the most common
pathogen causing acute gastroenteritis, and was detected
in 39% of children less than 5 years of age hospitalized for
diarrhea [31], leading to more than 4000 hospitalizations
countrywide annually [31]. Both Rotarix and RotaTeq
were licensed in Israel in mid-2007, but it was only in
December 2010 that RotaTeq was included in the na-
tional immunization program. The aims of this study were
to examine the incidence, clinical characteristics and po-
tential correlates of intussusception among children less
than five years of age from January 1st, 1992 to December
31st, 2009, before the introduction of rotavirus vaccine
into the national immunization program.
Methods
The study was conducted in two hospitals in northern
Israel: Carmel in Haifa and Hillel Yaffe in Hadera. The
population residing in the catchment area of the two
hospitals includes representation of the two major ethnic
groups of the Israeli population, Jews and Arabs. It is es-
timated that 20% and 90% of children aged 0–4 years in
Haifa and Hadera sub-districts, respectively, receive in-
patient services at these facilities. Based on this informa-
tion and on publications of the Israel Central Bureau of
Statistics the estimated number of children less than five
years of age residing in the study area ranged from 29,000
in 1992 to 40,700 in 2009 (annual average 35,600).
We identified children less than five years of age who
were hospitalized with intussusception (n = 190) at the
study hospitals between January 1st, 1992 and December
31st, 2009 by searching for the ICD-9 diagnosis code for
intussusception (560.0) in discharge records. All records with
this code were retrieved regardless of its being a primary or
secondary diagnosis. Also the word “intussusception” wassearched in text regardless of diagnosis coding. In both
hospitals, the diagnosis of intussusception was based on
radiological findings, usually ultrasound. In order to
examine the correlates of intussusception, we retrieved re-
cords of control children (N = 295) hospitalized for rea-
sons other than intussusception. The primary diagnoses of
the control children were trauma (50.3%), otitis media
(23.8%), local infection (17%) (e.g., cellulitis, abscess, mas-
toiditis, urinary tract infection), fever (4.1%), and elective
procedures/other (4.8%). From the archives of each hos-
pital, we retrieved lists of potential consecutive control
children with these diagnoses. Intussusception cases and
control children were frequently matched by hospital,
sex, season/date of admission (±2 months). We did not
strictly match cases and controls by age; however
knowing that the majority of cases were children under
one year of age we restricted the age of controls to
24 months or less. Both case and control groups con-
sisted of generally healthy children; 95% and 94% respect-
ively had no underlying significant health problems. A
control child with multiple hospitalizations was included
only once.
Using a standardized form, demographic and clinical in-
formation was collected including age, sex, hospitalization
date (month and year), maternal and paternal age, birth
weight, birth week, history of gastroenteritis prior to
hospitalization, breastfeeding, and significant medical
problems. For cases, data were also obtained on clinical
symptoms and treatment modality (e.g. air enema, barium
enema or surgery). Socioeconomic rank of place of resi-
dence according to the Israel Bureau of Statistics [32] was
used as a proxy measure of socioeconomic status; ranks
1–4, 5–6 and 7–10 were grouped as low, intermediate and
high socioeconomic status, respectively.
The study protocol was approved by the institutional re-
view board of Carmel medical center (Protocol number
0099-09-CMC) and Hillel Yaffe medical center (Protocol
number HYMC-0051-09), which allowed access to med-
ical records. Data abstraction was done by one person
(S.E.), and the identity of the patients was kept confi-
dential and was retained in the study hospitals.
Sample size and power calculation
Assuming that the yearly incidence of intussusception in
children less than five years of age is 35 per 100,000 chil-
dren, with 95% confidence intervals (CIs) and maximum
acceptable difference of 20 per 100,000 between the as-
sumed and true incidence, then the required sample size
was estimated at 33,602. The catchment area of the
study hospitals had on average 35,600 children less than
five years of age. Assuming a 30% prevalence of breast-
feeding (i.e., 70% not breastfed), and an odds ratio (OR)
for intussusception of 0.5 for children who are not
breastfed, with the available 190 cases and 295 controls,
Figure 1 The incidence of intussusception (per 100,000) by age, in a northern region of Israel 1992–2009.
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ference with two sided test.
Statistical analysis
The average annual incidence (per 100,000) and 95% CIs
of intussusception were calculated. Possible risk factors
for intussusception and those for surgery were examined
in intussusception patients, using Student t test for con-
tinuous variables and chi square test for categorical
variables, and multivariable stepwise logistic regression
models. The OR and 95% CI were obtained. The variablesFigure 2 The number of intussusception episodes by month of admisincluded in the analysis at step 1 were age, hospital, socio-
economic rank of place of residence, recent gastroenteritis
episode, and breastfeeding. Two sided P < 0.05 was con-
sidered statistically significant. Data were analyzed with
SPSS version 19.0. Imputation of missing values was not
performed. Our research adhered to the STROBE guide-
lines (Additional file 1).
Results
One hundred and ninety four hospitalizations for intussus-
ception in 190 children between 01.01.1992 and 12.31.2009sion in a northern region of Israel 1992–2009.
Table 1 Distribution of cases and controls by year, season
and sex
Cases, n (%) Controls, n (%) Pv
(N = 190) (N = 295)
Year
1992 7 (3.7) 17 (5.8) 0.45
1993 7 (3.7) 9 (3.1)
1994 15 (7.9) 24 (8.1)
1995 17 (8.9) 17 (5.8)
1996 6 (3.2) 15 (5.1)
1997 11 (5.8) 15 (5.1)
1998 12 (6.3) 15 (5.1)
1999 12 (6.3) 25 (6.1)
2000 22 (11.6) 36 (12.2)
2001 12 (6.3) 20 (6.8)
2002 7 (3.7) 7 (2.4)
2003 11 (5.8) 24 (8.1)
2004 4 (2.1) 11 (3.7)
2005 6 (3.2) 14 (4.7)
2006 12 (6.3) 16 (5.4)
2007 14 (7.4) 19 (6.4)
2008 12 (6.3) 4 (1.4)
2009 3 (1.6) 4 (1.4)
Season
Winter 46 (24.2) 74 (25.1) 0.93
Spring 48 (25.3) 73 (24.7)
Summer 48 (25.3) 68 (23.1)
Fall 48 (25.3) 80 (27.1)
Sex
Males 119 (62.6) 176 (59.7) 0.54
Females 71 (37.4) 118 40.1)
Ethnic group by hospital
Hillel Yaffe Medical Center
Arabs 49 (49.0) 56 (40.3)
Jews 51 (51.0) 83 (59.7) 0.24
Carmel Medical Center
Arabs 27 (30.0) 36 (23.2) 0.18
Jews 63 (70.0) 119 (76.8)
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age of intussusception patients was 10 [Standard deviation
(SD) 7] months; 65.3% were infants aged 3–11 months; 119
(62.6%) were boys. The most common symptom of intus-
susception was vomiting (77.3%), followed by irritability
(69.1%), parental reporting of abdominal pain (47.8%),
bloody stool (38.7%), lethargy (30.5%) and diarrhea (19.6%).
Bloody stool was more common in infants 0–11 months
of age than in children 12–59 months of age, 46.3% versus
19.6%, respectively, P < 0.001. Air enema, barium enema
and surgery were performed in 62.4%, 33.5%, and 23.2%
of the episodes, respectively. Median duration of hospital
stay was 2 days (range 1 to 12).
The overall annual incidence of intussusception was
estimated at 29.5 (95% CI 16.4-53.1) per 100,000; 36.1
(95% CI 17.0-76.5) and 23.2 per 100,000 (95% CI 9.3-
57.9) for Jewish and Arab children less than five years
of age, respectively. The corresponding estimates for in-
fants less than 12 months of age were 105.6 (95% CI 52.9-
210.7) per 100,000; 128.1 (95% CI 53.0-309.6) and 80.1
(95% CI 29.1-242.6) per 100,000 in Jewish and Arab in-
fants, respectively. There were year-to-year fluctuations
in the incidence of intussusception, with a general
trend of decline over the past few years (Figure 1).
No clear evidence of seasonality was found (Figure 2).
Children with intussusception and controls were simi-
lar in terms of sex, hospital, ethnic group and year
and season of admission (Table 1). The percentages
of children aged 3–5 and 6–11 months, those living
in low socioeconomic settings, and children with his-
tory of gastroenteritis prior to hospitalization were
significantly higher in cases than in controls (Table 2).
Toddlers aged 1–4 years who were not breasted had
a lesser likelihood of intussusception compared with
breastfed children (Table 2). In multivariable analysis,
associations with age, socioeconomic rank of town of
residence, and recent gastroenteritis remained signifi-
cant (Table 3). Since rotavirus vaccines were licensed
and became available in Israel by mid-2007, an add-
itional case–control analysis was performed including
only children admitted prior to 2007. The results of both
the bivariate and multivariable analyses were similar to
the full dataset analysis presented.
Among patients with intussusception, the percent-
age of those who underwent surgery was significantly
higher in infants, Arabs, residents of low socioeco-
nomic status settings, in patients who had bloody
stool and those admitted to Hillel Yaffe Medical Center
(Table 4). In multivariable analysis the odds for sur-
gery remained significantly 2-fold higher in patients
who presented with bloody stool, in Arabs and in those
who were admitted to Hillel Yaffe. Children who pre-
sented with diarrhea had lower odds for requiring
surgery (Table 5).Discussion
We estimated the incidence and correlates of intussus-
ception in northern Israel over 18 year period from
1992–2009, prior the introduction of universal rotavirus
immunization in Israel.
The estimated mean annual incidence of intussuscep-
tion among infants, 105.6 (95% CI 52.9-210.7) per 100,000
in this study, is slightly higher than the reported incidence
Table 2 Bivariate analysis of the risk factors for intussusception
Cases Controls OR (95% CI) Pv
Age (months), n (%)
< 3 10 (5.3) 33 (11.2) Reference <0.001
3-5 48 (25.3) 21 (7.1) 7.54 (3.14-18.07)
6-11 76 (40.0) 88 (29.8) 2.85 (1.31-6.16) 0.008
12-23 44 (24.4) 136 (46.1) 1.06 (0.48-2.34) 0.87
24-59 12 (6.3) 17 (5.8) 2.32 (0.83-6.48) 0.10
Paternal age (yrs), mean (SD)a 34.7 (5.8) 33.3 (5.6) 1.04 (0.99-1.09) 0.078
Maternal age (yrs), mean (SD)a 31.0 (5.1) 29.6 (5.1) 1.05 (1.00-1.11) 0.045
SES of residence town, n (%)a
Low 66 (42.9) 73 (29.4) 2.29 (1.32-3.97) 0.003
Intermediate 60 (39.0) 104 (41.9) 1.46 (0.85-2.51) 0.16
High 28 (18.2) 71 (28.6) Reference
Birth weight, n (%)
Birth weight < 2500 gra 6 (4.2) 14 (6.0) Reference 0.44
Birth weight ≥ 2500 gr 138 (95.8) 221 (94.0) 1.45 (0.54-3.88)
Birth week, n (%)
Less than 37 weeks 6 (4.3) 10 (4.6) Reference 0.86
≥ 37 weeks 135 (95.7) 206 (95.4) 1.09 (0.38-3.07)
Gastroenteritis before admission, n (%)
Yes 12 (6.3) 1 (0.3) 19.82 (2.55-153.72) <0.001
No 178 (93.7) 294 (99.7) Reference
Breastfeeding < 1 yr, n (%)
Breastfed aged < 1 yr 50 (37.3) 40 (28.2) Reference 0.10
Not breasted children aged <1 yr 84 (62.7) 102 (71.8) 0.65 (0.39-1.09)
Breastfeeding 1–4 yrs, n (%)
Breastfed children age 1-4 yrs 9 (16.1) 8 (5.2) Reference
Not breasted children age 1-4 yrs 47 (83.9) 145 (94.8) 0.28 (0.10-0.78) 0.011
aData on maternal and paternal age were available for 93 (47%) cases and 143 (48%) controls. Information on birth week was available for 141 (74%) cases and
216 (73%) controls, and on birth weight it was available for 144 (76%) cases and 235 (80%) controls. Information on SES of place of residence was available for
154 (81%) cases and 248 (84%) controls.
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reported in the United States [7,36]. The incidence of
intussusception in infants in this region of northern
Israel decreased over time, in concert with previous
studies [7,34,36,37].
The incidence of intussusception was higher among
Jewish than Arab children, in agreement with an earlier
study in southern Israel [10], where the incidence among
Jewish and Bedouin children less than five year of age
was estimated at 49.3 and 18.9 per 100,000, respectively,
and for infants 199.6 and 66.8 per 100,000, respectively
[10]. Ethnic differences in the incidence of intussuscep-
tion have been described before [7,9,36-38]. Higher risk
of intussusception has been noted among black and
Hispanic children vs white, non-Hispanic children in the
United States [7,36,38]. In Australia and New Zealandlower incidence of intussusception was observed in indi-
genous infants compared to non-indigenous infants [37],
and specifically, among Maori compared with European
infants, respectively [9].
About two thirds of intussusception cases occurred in
infants 3–11 months of age; the risk of intussusception
increased substantially by 5 fold in children aged 3–5
months compared to younger infants while children
aged 6–11 months had about 2-fold increased risk of
intussusception compared to the youngest age group
(<3 months). Increased risk of intussusception was found
more among children who lived in low socioeconomic
communities than among those who lived high socioeco-
nomic settings. A previous study from the United States
showed that infants enrolled in Medicaid, used as a marker
for low socioeconomic status, had 1.5 fold increased risk of
Table 3 Multivariable logistic regression model of the risk
factors for intussusception in children less than 5 years
of age
Adjusted OR (95% CI)* Pv
Age (months)
<3 Reference
3-5 5.30 (2.11-13.31) <0.001
6-11 2.53 (1.13-5.62) 0.023
12-23 0.73 (0.32-1.65) 0.4
24-59 2.01 (0.73-5.99) 0.1
Socioeconomic rank
of place of residence
Low 2.81 (1.45-5.43) 0.002





Yes 19.90 (2.35-168.32) 0.006
*Variables entered to the model at step 1: age, socioeconomic rank of place of
residence, history of gastroenteritis, hospital, and breastfeeding. Data presented
in the table are the final model which included the variables in the table
and hospital.
Table 4 Correlates of surgery among cases with
intussusception
Total Surgery, n (%) Pv
Age
< 1 year 134 36 (26.9) 0.11
1-4 years 56 9 (16.1)
Sex
Males 119 33 (27.7) 0.089
Females 71 12 (16.9)
Ethnic group
Arabs 76 25 (32.9) 0.015
Jews 114 20 (17.5)
Socioeconomic rank of residence place
Low 66 21 (31.8) 0.006
Intermediate 60 11 (18.3)
High 28 2 (7.1)
Hospital
Hillel Yaffe Medical Center 100 33 (33.0) 0.001
Carmel Medical Center 90 12 (13.3)
Breastfeeding
Breastfed 59 17 (28.8) 0.26
Not breasted 131 28 (21.4)
Blood in the stool
No 117 22 (18.8) 0.045
Yes 73 23 (31.5)
Vomiting
No 44 6 (13.6) 0.074
Yes 146 39 (26.7)
Diarrhea
No 154 41 (26.6) 0.052
Yes 36 4 (11.1)
Irritability
No 59 17 (28.8) 0.26
Yes 131 28 (21.4)
Table 5 Multivariable analysis of factors associated with






Hillel Yaffe Medical Center
vs. Carmel Medical Center
3.20 (1.53-6.69) 4.42 (1.70-11.46) 0.002
Arabs vs. Jews 2.30 (1.16-4.54) 2.32 (0.99-5.45) 0.05
Blood in the stool (yes vs. no) 1.98 (1.00-3.91) 2.78 (1.17-6.60) 0.021
Diarrhea (yes vs. no) 0.34 (0.11-1.03) 0.22 (0.05-1.1) 0.06
*In addition to the variables in the table, the variables socioeconomic status of
place of residence, age, sex, and interaction between ethnicity and hospital
were added to the analysis. The adjusted ORs and Pv presented in the table
were obtained from the final model.
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anisms might explain the association of intussusception
and socioeconomic strata, but it is possible that genetic,
environmental and cultural exposures including exposure
to enteric pathogens and child nutritional practices [3]
may play a role. In this study, recent history of gastro-
enteritis was associated with increased the risk of intus-
susception, and similar findings have been shown in other
studies [11,12]. However, it is possible that our findings
overestimate such an association, since physicians may
have questioned parents of control children less inten-
sively than intussusception patients’ parents on a recent
history of gastroenteritis.
The common clinical symptoms of intussusception were
similar to those reported previously; it is worth mention-
ing that visible (macroscopic) blood in stool was docu-
mented in only 39% of cases, and it appeared more than
twofold in infants compared with toddlers. Irritability was
also common, reported in 69%. This is probably due to
the fact that infants and young children lack the ability to
express pain verbally. These findings suggest that suspect-
ing intussusception in children presenting with “atypical”
symptoms is warranted.
The median hospital stay was 2 days, but reached 12 days
in some cases. Usually, reduction with conservative treat-
ment like air or barium enema was successful, but surgery
was required in about 1/4 of intussusception patients. The
percentage of intussusception patients undergoing sur-
gery varied widely in previous studies - from 12% to
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stool, Arabs, and those who were admitted to Hillel Yaffe
Medical Center were more likely to undergo surgery. Des-
pite the lower incidence of intussusception among Arab
children, they underwent surgery about twice as often as
did Jewish children. Interestingly a previous study from
southern Israel also showed that Bedouin children with in-
tussusception were more likely to undergo surgery than
their Jewish peers [10]. However, in the southern Israel,
about 50% of the Bedouin population lives in remote vil-
lages so that limited access to primary health care might
explain why Bedouin children require surgery more often.
This is not the case in northern Israel. In the study area,
despite the fact that Arab residents live mostly in separate
towns and villages, all have a basic infrastructure similar to
that of Jewish communities, including on-site primary care
clinics run by the main health maintenance organizations.
Furthermore, in 1995 the National Health Insurance law
was implemented in Israel, resulting in near uniform ac-
cess to health care, preventive, ambulatory and inpatient
services, thus minimizing disparities between Arab and
Jewish populations. In the United States bowel resection
was significantly increased in patients who had the symp-
toms for 2 days or more before admission compared
to those who were admitted earlier [38]. Therefore, tak-
ing into account the characteristics of the study communi-
ties we postulate that admission may be delayed in some
Arab patients with intussusception. This may be due to
different referral behaviors of community physicians in
Arab towns, parental perception of intussusception symp-
toms as non-serious (e.g., mistakenly confused with
gastroenteritis), or both. If this hypothesis is proven true,
the potential exists to reduce the need for intussus-
ception surgery, especially in Arab children, by educating
parents on when to seek medical care for young children
with possible intussusception, and when pediatric care-
givers in community practice should refer children to hos-
pital for suspected intussusception. This finding may be
relevant to countries with multiple ethnicities as well.
Since mostly Arab physicians work in clinics in the Arab
towns and villages, there is a possibility of a combined
doctor-patient ethnic effect upon the decision whether
or not to refer patients to hospital for further evalu-
ation. Since the incidence of intussusception in Arab
children is lower than that found among Jewish children,
seeking medical attention might be delayed for intussus-
ception with mild symptoms which might, in some cases,
resolve spontaneously. This could lead to higher risk esti-
mates for surgery among Arab vs. Jewish children. There-
fore, the average incidence of intussusception associated
with surgery was calculated, and was found to be higher
among Arab vs. Jewish children (7.50 vs. 6.83 per 100,000
children less five years of age, but this difference was not
significant).The review of hospital records over an 18 year period
from 2 hospitals in northern Israel yielded robust esti-
mates of the incidence of intussusception, its clinical
symptoms and treatment strategies prior the introduc-
tion of universal rotavirus immunization in Israel. The
diagnosis of intussusception relied on radiological and/
or sonographic findings throughout the study period in
both medical centers. A case–control design was utilized
to obtain insight in to the correlates of intussusception.
These can be regarded as strengths of the study. Yet the
study has some notable weaknesses: variability in obtain-
ing clinical history probably occurred over time and
among pediatricians. Hospital controls may not be the
optimal control group, yet these groups were from the
same source population and were comparable in terms
of sex, study period, geographic region and ethnicity.
Conclusions
We documented a relatively low incidence of pediatric
intussusception prior the introduction of universal rota-
virus immunization in Israel, but higher than that found
in European and US children. Although incidence was
lower among Arabs than Jews, the former group was more
likely to undergo surgery, suggesting the possibility of de-
layed admission of Arab patients to hospital resulting
from specific referral patterns of physicians and/or health
care seeking behaviors of parents. These findings have
public health and clinical implications.
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